Author： Gentzler Ryan D Altman Jessica K Platanias Leonidas C
Publisher： Informa Healthcare
ISSN： 1472-8222
Source： Expert Opinion on Therapeutic Targets, Vol.16, Iss.5, 2012-05, pp. : 481-489
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
The mTOR Pathway: A New Target in Cancer Therapy
Current Cancer Drug Targets, Vol. 10, Iss. 5, 2010-08 ,pp. :
Access to resources
Recommend
mTOR Pathway and mTOR Inhibitors as Agents for Cancer Therapy
Current Cancer Drug Targets, Vol. 8, Iss. 8, 2008-12 ,pp. :
mTOR pathway inhibitors in cancer therapy: moving past rapamycin
Pharmacogenomics, Vol. 11, Iss. 9, 2010-09 ,pp. :
Inhibitors of mTOR pathway for cancer therapy, moving on from rapalogs to TORKinibs
Cancer, Vol. 121, Iss. 19, 2015-10 ,pp. :
Targeting mTOR Signaling Pathway in Ovarian Cancer
Current Medicinal Chemistry, Vol. 18, Iss. 19, 2011-06 ,pp. :